If 70% of your immune system lives in your gut, then your microbiome may be one of the most powerful tools you have in your cancer journey.
In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explains why the gut lining — packed with immune cells, microbes, and signaling pathways — determines how well you respond to chemotherapy, immunotherapy, and precision-built biologics.
You’ll learn how chemotherapy, toxins, processed foods, and chronic inflammation disrupt the gut wall, lowering microbial diversity and weakening the immune system. Dr. Prato also highlights key species like Akkermansia and Bifidobacteria, which repeatedly show up in research as strong predictors of immunotherapy success.
Discover how resistant starches, fermented foods, polyphenols, healthy fats, and superfoods — combined with targeted prebiotics, probiotics, and beta-glucans — help rebuild the gut ecosystem. Small, gradual changes can restore microbial diversity, reduce inflammatory cytokines, improve NK and dendritic cell activity, and strengthen overall immunity.
🎯 What You’ll Learn in This Episode:
• Why 70–80% of immune cells live in the gut
• How microbiome diversity predicts immunotherapy response
• The impact of chemotherapy-induced dysbiosis on immunity
• Best foods to rebuild the gut: fermented foods, resistant starches, polyphenols
• Why Akkermansia & Bifidobacteria matter for anti-tumor immunity
• How to lower inflammation, improve gut lining repair, and boost NK cells
• Why slow dietary changes beat extreme shifts for long-term gut healing
📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak to a care coordinator: 866-830-4576
Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at:
https://www.scirp.org/journal/paperinformation?paperid=132493
